The multidrug-resistant opportunist Stenotrophomonas maltophilia plays a central role in one of our projects: it is part of mixed biofilms in which the interactions between pulmonary opportunists and emerging antimicrobial resistance are studied (IPT2, further description HERE). At the highly respected American Society for Microbiology (ASM) conference "ASM Microbe 2022" held in June, there was intense discussion about this pathogen, which is increasingly developing resistance to conventional drugs.  The video recorded live in Washington DC is available HERE .